Sorbent augented dialysis systems

Contributions to Nephrology

Volumn 137, Issue , 2002, Pages 170-180

  Winchester, F J ^a   Ronco, C ^b   Salsberg, J ^a   Yousha, E ^a   Brady, J A ^a   Cowgill, L D ^c   Choquette, M ^a   Albright, R ^a   Clemmer, J ^a   Davankov, V ^e   Tsyurupa, M ^e   Pavlova, L ^e   Pavlov, M ^e   Cohen, G ^f   Horl W ^f   Gotch, F ^d   Levin, N W ^g  

^a RenalTech International   (United States)

^b SAN BORTOLO HOSPITAL   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

^f UNIVERSITY OF VIENNA   (Austria)

^g RENAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL;

ADSORPTION; ARTIFICIAL LIVER; HUMAN; INSTRUMENTATION; METHODOLOGY; ONLINE SYSTEM; RENAL REPLACEMENT THERAPY; REVIEW;

ADSORPTION; BIOCOMPATIBLE MATERIALS; HUMANS; LIVER, ARTIFICIAL; ONLINE SYSTEMS; RENAL DIALYSIS;

EID: 18544407953     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (63)

1. Roberts M: The status of sorbent technology in hemodialysis treatment. Clin Nephrol 1986;26(suppl 1):S44-S46.
2. Winchester JF, Ronco C: Hemoperfusion in uremia: An in-depth review. Adv Renal Replace Ther, in press.
3. Winchester JF, Ronco C, Brady JA, Brendolan A, Davankov V, Tsyurupa M, Pavlova L, Pavlov M, Clemmer J, Polaschegg HD, Muller TE, La Greca G, Levin NW: Rationale for combined hemoperfusion/hemodialysis in uremia. Contrib Nephrol. Karger, Basel, 2001, vol 133, pp 174-179.
4. Winchester JF, Ronco C, Brady JA, Cowgill LD, Salsberg J, Yousha E, Choquette M, Albright R, Clemmer J, Davankov V, Tsyurupa M, Pavlova L, Pavlov M, Cohen G, Horl W, Gotch F, Levin NW: The next step from high-flux dialysis: Application of sorbent technology. Blood Purif 2002;20:81-86.
5. Mikhalovsky S: The detoxication with bioselective carbon sorbents. Biomater Artif Cells Artif Organs 1989;17:157-160.
6. Dhondt A, Vanholder R, Van Biesen W, Lameire N: The removal of uremic toxins. Kidney Int 2000;58(suppl 76):S47-S59.
7. Haag-Weber M, Cohen G, Horl WH: Clinical significance of granulocyte-inhibiting proteins. Nephrol Dial Transplant 2000;15(suppl 1):15-16.
8. Marinez de Francisco AL, Ghezzi PM, Brendolan A, Fiorini F, La Greca G, Ronco C, Arias M, Gervasio R, Tetta C: Hemodiafiltration with online regeneration of the ultrafiltrate. Kidney Int 2000;58(suppl 76):S66-S71.
9. Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W: A comparison of On-line hemodiafiltration and high-flux hemodialysis: A prospective clinical study. J Am Soc Nephrol 2000;11:2344-2350.
10. Takenaka T, Itaya Y, Tsuchiya Y, Kobayashi K, Suzuki H: Fitness of Biocompatible high-flux hemodiafiltration for dialysis-related amyloidosis. Blood Purif 2001;19:10-14.
11. Samtleben W, Gurland HJ, Lysaght MJ, Winchester JF: Plasma exchange and hemoperfusion; in Jacobs C, Kjellstrand CM, Koch KM, Winchester JF (eds): Replacement of Renal Function by Dialysis. Dordrecht, Kluwer Academic Publishers, 1996, pp 472-500.
12. 2-microglobulin in hemodialysis. Blood Purif 2001;19:260-263.
13. Memoli B, Postiglione L, Cianciaruso B, Bisesti V, Cimmaruta C, Marzano L, Minutolo R, Cuomo V, Guida B, Andreucci M, Rossi G: Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients. Kidney Int 2000;58:417-424.
14. Guth HJ, Gruska S, Kraatz G: The measurement of cytokine production capacity during dialysis: A new dynamic method for the evaluation of biocompatibility? Int J Artif Organs 2000;23:675-679.
15. Inagi R, Miyata T: Oxidative protein damage with carbohydrates and lipids in uremia: 'Carbonyl stress'. Blood Purif 1999;17:95-98.
16. Don BR, Kaysen GA: Assessment of inflammation and nutrition in patients with end-stage renal disease. J Nephrol 2000;13:249-259.
17. Ferreira A, Drueke TB: Biological markers in the diagnosis of the different forms of renal osteodystrophy. Am J Med Sci 2000;320:85-89.
18. 2-microglobulin. Biochem Biophys Res Commun 1985;129:701-706.
19. 2-Microglobulin modified with AGE products of the Maillard reaction in dialysis related amyloidosis; in Maeda K, Shinzato T (eds): Dialysis-Related Amyloidosis. Contrib Nephrol. Basel, Karger, 1995, vol 112:, pp 52-64.
20. 2-microglobulin turnover in dialyzed patients. Kidney Int 1992;42:1434-1443.
21. Drueke TB: Beta-2-microglobulin and amyloidosis. Nephrol Dial Transplant 2000;15(suppl 1):17-24.
22. Tan SY, Baillod R, Brown E, Farrington K, Soper C, Percy M, Clutterbuck E, Madhoo S, Pepys MB, Hawkins PN: Clinical, radiological and serum amyloid P component scintigraphic features of beta-2-microglobulin amyloidosis associated with continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1999;14:1467-1471.
23. Westhuyzen J, Foreman K, Battistutta D, Saltissi D, Fleming SJ: Effect of dialyzer reprocessing with renalin on serum beta-2-microglobulin and complement activation in hemodialysis patients. Am J Nephrol 1992;12:29-36.
24. Leypoldt JK, Cheung AK, Deeter RB: Effect of dialyzer reuse: Dissociation between clearances of small and large solutes. Am J Kidney Dis 1998;32:295-301.
25. Koda Y, Nishi S, Miyazaki S, Haginoshita S, Sakurabayashi T, Suzuki M, Sakai S, Yuasa Y, Hirasawa Y, Nishi T: Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 1997;52:1096-1101.
26. Snyder HW Jr, Cochran SK, Balint JP Jr, Bertram JH, Mittelman A, Guthrie TH Jr, Jones FR: Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura. Blood 1992;79:2237-2245.
27. Bosch T, Lennertz A, Kordes B, Samtleben W: Low density lipoprotein hemoperfusion by direct adsorption of lipoproteins from whole blood (DALI apheresis): Clinical experience from a single center. Ther Apher 1999;3:209-213.
28. Davankov V, Pavlova L, Tsyurupa M, Brady J, Balsamo M, Yousha E: Polymeric adsorbent for removing toxic proteins from blood of patients with kidney failure. J Chromatogr [B] 2000;739:73-80.
29. Mertens PR, Schonfelder T, Handt S, Kierdorf H, Marschall H, Busch N, Heintz B, Sieberth H: Long-term extracorporeal bilirubin elimination: A case report on cascade resin plasma perfusion. Blood Purif 1998;16:341-348.
30. Sato T, Orlowski JP, Zborowski M: Experimental study of extracorporeal perfusion for septic shock. ASAIO J 1993;39:M790-M793.
31. Pond SM: Extracorporeal techniques in the treatment of poisoned patients. Med J Aust 1991; 154:617-622.
32. Ronco C, Brendolan A, Winchester JF, Golds E, Clemmer J, Polaschegg HD, Muller TE, Davankov V, Tsyurupa M, Pavlova L, Pavlov M, La Greca G, Levin NW: First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta 2-microglobulin in hemodialysis. Contrib Nephrol. Basel, Karger, 2001, vol 133, pp 166-173.
33. Steczko J, Ash SR, Blake DE, Carr DJ, Bosley RH: Cytokines and endotoxin removal by sorbents and its application in push-pull sorbent-based pheresis: The BioLogic-DTPF System. Artif Organs 1999;23:310-318.
34. Lang HL, Nolph KD, McGary TJ: Enhancement of clearances by activated charcoal in an in vitro model of peritoneal dialysis. Clin Exp Dial Apheresis 1982;6:85-95.
35. Blumenkrantz MJ, Lewin AJ, Gordon A, Roberts M, Pecker EA, Coburn JW, Maxwell MH: Development of a sorbent peritoneal dialysate regeneration system: A progress report. Proc Eur Dial Transplant Assoc 1978;15:213-219.
36. Gordon A, Maxwell MH, Lewin AJ: Sorbent regeneration of peritoneal dialysate: An approach to ambulatory dialysis. J Dial 1976-77;1:145-164.
37. Roberts M, Ash SR, Lee DB: Innovative peritoneal dialysis: Flow-thru and dialysate regeneration. ASAIO J 1999;45:372-378.
38. Martin AM, Gibbins JK, Kimmitt J, Rennie F: Hemodialysis and hemoperfusion in the treatment of uremic pericarditis: A study of 13 cases. Dial Transplant 1979;8:135.
39. Odaka M, Kirasawa H, Kobayashi H, Ohkawa M, Soeda K, Tabata Y, Soma M, Sato H: Clinical and fundamental studies of cellulose coated bead-shaped charcoal haemoperfusion in chronic renal failure; in Sideman S, Chang TMS (eds): Hemoperfusion, Kidney and Liver Support and Detoxification. Washington, Hemisphere Publishing, 1980, p 45.
40. Trznadel K, Luciak M, Wyszogrodzka M: Effect of haemoperfusion on the left ventricular systolic function in patients with chronic uraemia. Acta Med Pol 1981;22:75.
41. Otsubo O, Kuzuhara K, Simada Y, Yamauchi Y, Taahashi 1, Yamada Y, Otsubo K, Inou T: Treatment of uraemic peripheral neuritis by direct haemoperfusion with activated charcoal. Proc Eur Dial Transplant Assoc 1979;16:731.
42. Agishi T, Yamashita N, Ota K: Clinical results of direct charcoal hemoperfusion for endogenous and exogenous intoxication; in Sideman S, Chang TMS (eds): Hemoperfusion, Kidney and Liver Support and Detoxification, Washington, Hemisphere Publishing, 1980, p 255.
43. Chang TMS, Barre P, Kuruvilla S: Long-term reduced time hemoperfusion-hemodialysis compared to standard dialysis: A preliminary crossover analysis. Trans Am Soc Artif Intern Organs 1985;31:572.
44. Henderson IS, Kennedy AC: Long-term evaluation of charcoal haemoperfusion combined with dialysis for uraemic patients; in Paul JP, Gaylor JDS, Courtney JM, Gilchrist T (eds): Biomaterials in Artificial Organs. London, Macmillan Press, 1984, p 72.
45. Odaka M, Tabata Y, Kabayashi H, Nomura Y, Soma A, Hirasawa A, Sato H: Clinical experience of bead-shaped charcoal hemoperfusion in chronic renal failure and fulminant hepatic failure; in Chang TMS (ed): Artificial Kidney, Artificial Liver and Artificial Cells. New York, Plenum Press, 1978, p 79.
46. Bonomini V, Stefoni S, Feliciangeli G, Coli L, Scolari MP, Orsi C, Nanni Costa A, Prandini R, Galanti S: Shortened treatment time by combined hemodialysis and hemoperfusion. Contr Nephrol. Basel, Karger, 1985, vol 44, p 57.
47. Chang TMS, Barre P: Effect of desferrioxamine on removal of aluminum and iron by coated charcoal haemoperfusion and haemodialysis. Lancet 1983;ii:1051-1053.
48. Winchester JF: Management of iron overload in dialysis patients. Semin Nephrol 1986;4(suppl 1): 22-26.
49. Vasilakakis DM, D'Haese PC, Lamberts LV, Lemoniatou E, Digenis PN, De Broe ME: Removal of aluminoxamine and ferrioxamine by charcoal hemoperfusion and hemodialysis. Kidney Int 1992;41:1400-1407.
50. Ronco C, Brendolan A, Dan M, Piccinni P, Bellomo R, Wratten ML, Inguaggiato P, Tetta C: Use of sorbents in acute renal failure and sepsis. Contrib Nephrol. Basel, Karger, 2001, vol 133, pp 180-193.
51. Brendolan A, Irone M, Digno A, Cioffi M, Piccinni P, Dan M, Tetta C, Ronco C: Coupled plasma filtration-adsorption technique (CPAT) in sepsis-associated acute renal failure. J Am Soc Nephrol 1998;9:127A.
52. de Francisco AL, Pinera C, Heras M, Rodrigo E, Fernandez Fresnedo G, Ruiz JC, Tetta C, Arias M: Hemodiafiltration with on-line endogenous reinfusion. Blood Purif 2000;18:231-236.
53. Marinez de Francisco AL, Ghezzi PM, Brendolan A, Fiorini F, La Greca G, Ronco C, Arias M, Gervasio R, Tetta C: Hemodiafiltration with online regeneration of the ultrafiltrate. Kidney Int 2000;76(suppl):S66-S71.
54. Opal SM: Hemofiltration-absorption systems for the treatment of experimental sepsis: Is it possible to remove the 'evil humors' responsible for septic shock? Crit Care Med 2000;28:1681-1682.
55. Roberts M: The status of sorbent technology in hemodialysis treatment. Clin Nephrol 1986;26(suppl 1):S44-S46.
56. Winchester JF, Ratcliffe JG, Carlyle E, Kennedy AC: Solute, amino acid, and hormone changes with coated charcoal hemoperfusion in uremia. Kidney Int 1978;14:74-81.
57. 2-microglobulin adsorbent during hemoperfusion with human whole blood. J Am Soc Nephrol 2000;11:257A.
58. Cohen G: Personal communication, 2002.
59. Brady JA, Potempska A, Ronco C, Yousha E, Muller T, Levin N: Ex vivo cytokine clearance with a new adsorbent material from endotoxin-stimulated whole blood. J Am Soc Nephrol 2000;11:586A.
60. Kellum J: Pers commun, 2002.
61. Jaber B: Pers commun, 2002.
62. Homma N, Gejyo F, Hasegawa S, Teramura T, Ei I, Maruyama H, Arakawa M: Effects of a new adsorbent column for removing beta-2-microglobulin from circulating blood of dialysis patients; in Maeda K, Shinzato T (eds): Dialysis-Related Amyloidosis. Contrib Nephrol. 1995, vol 112, pp 164-171.
63. Hyodo T, Tiara T, Hiyama E, et al: The clinical study on the newer type (Lixelle Type S-15) of the direct hemoperfusion B2-MG adsorption column. J Am Soc Nephrol 2001;12:267A.